Dwek Raymond's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jul 11, 2022
- Accession no.
- 0001415889-22-007625
- Filed
- Jul 11, 2022
- Trade date
- Jul 7-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $521.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dwek RaymondCIK 0001231617 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | MOption exerciseAcquired | +2,160 | $0.00F1 | $0 | 2,160 | Direct | |
| Jul 11, 2022 | Common Stock | SSaleDisposed | −2,160 | $241.29 | −$521,186.4 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | MOption exerciseDisposed | −2,160 | $0.00 | $0 | 0 | Direct | |
| Jul 7, 2022 | Common Stock | AGrant or awardAcquired | +1,750 | $0.00 | $0 | 1,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
Referenced by the price of 1 transaction in Table I.